T-Cell Cytokines as Predictive Markers of the Risk of Allograft Rejection

免疫抑制 医学 免疫学 移植 药效学 促炎细胞因子 免疫系统 移植排斥反应 代理终结点 药理学 药代动力学 内科学 炎症
作者
Mercé Brunet,Olga Millán López,Marcos López‐Hoyos
出处
期刊:Therapeutic Drug Monitoring [Ovid Technologies (Wolters Kluwer)]
卷期号:38 (Supplement 1): S21-S28 被引量:13
标识
DOI:10.1097/ftd.0000000000000253
摘要

Over the last decade, several biomarkers and surrogate markers have surfaced as promising predictive markers of risk of rejection in solid organ transplantation. The monitoring of these markers can help to improve graft and recipient care by personalizing immunomodulatory therapies. The complex immune system response against an implanted graft can change during long-term follow-up, and the dynamic balance between effector and regulatory T-cell populations is a crucial factor in antidonor response, risk of rejection, and immunosuppression requirements. Therefore, at any time before and after transplantation, T-effector activity, which is associated with increased production and release of proinflammatory cytokines, can be a surrogate marker of the risk of rejection and need for immunosuppression. In addition, immunosuppressive drugs may have a different effect in each individual patient. The pharmacokinetics and pharmacodynamics of these drugs show high interpatient variability, and pharmacodynamic markers, strongly associated with the specific mechanism of action, can potentially be used to measure individual susceptibility to a specific immunosuppressive agent. The monitoring of a panel of valid biomarkers can improve patient stratification and the selection of immunosuppressive drugs. After transplantation, therapy can be adjusted based on the prediction of rejection episodes (maintained alloreactivity), the prognosis of allograft damage, and the individual's response to the drugs. This review will focus on current data indicating that changes in the T-cell production of the intracellular cytokines interferon-γ and interleukin-2 could be used to predict the risk of rejection and to guide immunosuppressive therapy in transplant recipients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无花果应助科研通管家采纳,获得10
刚刚
思源应助科研通管家采纳,获得10
1秒前
大模型应助科研通管家采纳,获得10
1秒前
852应助科研通管家采纳,获得10
1秒前
爆米花应助科研通管家采纳,获得30
1秒前
1秒前
华仔应助科研通管家采纳,获得10
1秒前
CipherSage应助科研通管家采纳,获得10
1秒前
隐形曼青应助科研通管家采纳,获得10
1秒前
1秒前
乐乐应助科研通管家采纳,获得10
1秒前
脑洞疼应助科研通管家采纳,获得10
1秒前
JamesPei应助科研通管家采纳,获得30
1秒前
苏卿应助科研通管家采纳,获得20
1秒前
WWXWWX应助科研通管家采纳,获得10
2秒前
科目三应助科研通管家采纳,获得10
2秒前
慕青应助科研通管家采纳,获得10
2秒前
2秒前
2秒前
2秒前
2秒前
桂桂完成签到,获得积分10
3秒前
Jouleken完成签到,获得积分10
3秒前
Sci完成签到,获得积分10
5秒前
糖糖糖唐完成签到,获得积分10
5秒前
JingFanGao完成签到,获得积分10
5秒前
zrw发布了新的文献求助10
5秒前
Gan完成签到,获得积分10
7秒前
希望天下0贩的0应助mbf采纳,获得10
7秒前
7秒前
科研通AI2S应助dan1029采纳,获得10
8秒前
CodeCraft应助dan1029采纳,获得10
8秒前
想睡觉的小笼包完成签到 ,获得积分10
9秒前
毕十三完成签到,获得积分10
10秒前
行走江湖的破忒头完成签到,获得积分0
10秒前
11秒前
三石发布了新的文献求助10
13秒前
13秒前
咩咩完成签到,获得积分10
14秒前
snnn完成签到,获得积分10
15秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
ALA生合成不全マウスでの糖代謝異常の分子機構解析 520
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
2-Acetyl-1-pyrroline: an important aroma component of cooked rice 500
A real-time energy management strategy based on fuzzy control and ECMS for PHEVs 400
Handbook on People's China (1957) 400
2024 Medicinal Chemistry Reviews 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3190354
求助须知:如何正确求助?哪些是违规求助? 2839625
关于积分的说明 8024732
捐赠科研通 2502549
什么是DOI,文献DOI怎么找? 1336609
科研通“疑难数据库(出版商)”最低求助积分说明 637841
邀请新用户注册赠送积分活动 606051